PURPOSE. Extensive Literature shows that Pax-6 is critical fur lens develop
ment and that Pax-6 mutations can result in aniridia in humans. In addition
, it has been reported that truncated Pax-6 molecules can act as dominant-n
egative repressors of wild-type Pax-6 activity in cultured cells. This stud
y was designed to determine whether Pax-6 molecules without either the acti
vation domain (AD) or the homeodomain (HD) and the AD can function as domin
ant-negative repressors in vivo and alter the phenotype of the lens.
METHODS. Transgenic mice were created harboring the alpha A-crystallin prom
oter linked to a cDNA encoding either a truncated Pax-6 without the C termi
nus (paired domain [PD] + homeodomain) or Pax-6 consisting of only the PD.
The phenotype of the resultant animals was investigated by light and electr
on microscopy as well as atomic absorption spectroscopy.
RESULTS. Two lines of PD + HD mice and three lines of PD mice were generate
d,all of which exhibit posterior nuclear and/or cortical cataracts of varia
ble severity. The lenses from mice transgenic for either Pax-6 truncation a
re smaller and more hydrated than normal. Morphologically, the mice express
ing the PD + HD of Pax-6 have swollen lens fibers with attenuated ball-and-
socket junctions. In contrast, the lenses from mice overexpressing the PD o
f Pax-6 have posterior nuclear cataracts composed of cell debris, whereas t
he remaining fiber cells appear generally normal.
CONCLUSIONS. The presence of truncated Pax-6 protein in the lens is suffici
ent to induce cataract in a wild-type genetic background. The simplest expl
anation for this phenomenon is a dominant-negative effect; however, a numbe
r of other possible mechanisms are presented.